Drug hypersensitivity syndrome: Drug rash with eosinophilia and systemic symptoms (DRESS)

Journal of Dermatological Treatment

Volumn 10, Issue 4, 1999, Pages 267-272

  Vaillant, L ^a  

^a UNIVERSITY HOSPITAL OF TOURS   (France)

Author keywords

Drug eruption; Eosinophilia; Hypersensitivity syndrome

Indexed keywords

ALLOPURINOL; ANTICONVULSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; CARBAMAZEPINE; CD8 ANTIGEN; CORTICOSTEROID; CYCLOSPORIN; DAPSONE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DRUG METABOLITE; EPOXIDE HYDROLASE; FELBAMATE; GOLD SALT; HYDANTOIN; LAMOTRIGINE; MINOCYCLINE; PHENOBARBITAL; PHENYTOIN; SULFAMETHOXAZOLE; SULFONAMIDE; SULFONE; SULFONYLUREA; VALPROIC ACID;

ANGIOIMMUNOBLASTIC LYMPHADENOPATHY; BULLOUS SKIN DISEASE; DELAYED HYPERSENSITIVITY; DIFFERENTIAL DIAGNOSIS; DRUG ACETYLATION; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG METABOLISM; EOSINOPHILIA; EXFOLIATIVE DERMATITIS; FEVER; HYPEREOSINOPHILIA; IMMUNE RESPONSE; KIDNEY DISEASE; LEUKOCYTE; LIVER DISEASE; LYMPHADENOPATHY; PATHOGENESIS; PRIORITY JOURNAL; PURPURA; PUSTULOSIS; RASH; REVIEW; SEZARY SYNDROME; SYNDROME DELINEATION; T LYMPHOCYTE; TOXIC HEPATITIS;

EID: 0033369785     PISSN: 09546634     EISSN: None     Source Type: Journal    
DOI: 10.3109/09546639909056043     Document Type: Review

References (68)

1. Salzstein SL, Ackerman LV, Lymphadenopathy induced by anti-convulsant drugs and mimicking clinically and pathologically malignant lymphomas. Cancer (1959) 12: 164-82.
2. Schreiber MM, McGregor JG, Pseudolymphoma syndrome. A sensitivity to anticonvulsant drugs. Arch Dermatol (1968) 97: 297-300.
3. Wilson JT, Hojer B, Tomson G et al, High incidence of a concentration dependent skin reaction in children treated with phenytoin. BMJ (1978) 1: 1583-6.
4. Engel JN, Mellul VG, Goodman D, Phenytoin hypersensitivity: a case of severe acute rhabdomyolysis. Am J Med (1986) 81: 928-30.
5. Michael JR, Mitch WE, Reversible renal failure and myositis caused by phenytoin hypersensitivity. JAMA (1976) 236: 2773-5.
6. Stanley J, Fallon-Pellicci V, Phenytoin hypersensitivity reactions. Arch Dermatol (1978) 114: 1350-3.
7. Chaiken BH, Goldberg BI, Segal JP, Dilantin hypersensitivity: report of a case of hepatitis with jaundice, pyrexia and exfoliative dermatitis. N Engl J Med (1950) 242: 897-8.
8. Conger LA, Grabski WJ, Dilantin hypersensitivity reaction. Cutis (1996) 57: 223-6.
9. Haruda F, Phenytoin hypersensitivity: 38 cases. Neurology (1979) 29: 1480-5.
10. Harris DWS, Ostlere L, Buckley C et al, Phenytoin-induced pseudolymphoma. A report of a case and review of the literature. Br J Dermatol (1992) 127: 403-6.
11. D'Incan M, Souteyrand P, Bignon YJ et al, Hydantoin-induced cutaneous pseudolymphoma with clinical, pathologic, and immunologic aspects of Sezary syndrome. Arch Dermatol (1992) 128: 1371-4.
12. Rosenthal CJ, Noguera CA, Cappola A, Kapelner SN, Pseudo lymphoma with mycosis fungoides manifestations, hyperresponsiveness to diphenylhydantoin, and lymphocyte deregulation. Cancer (1982) 49: 2305-14.
13. Shear NH, Spielberg SP, Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. J Clin Invest (1988) 82: 1826-32.
14. Parneix-Spake A, Bastuji-Garin S, Lobut JB et al, Minocycline as possible cause of severe and protracted hypersensivity drug reaction. Arch Dermatol (1995) 131: 490-1.
15. Brown MD, Ellis CN, Billings J et al, Rapid occurrence of nodular cutaneous T-lymphocyte infiltrates with ciclosporine therapy. Arch Dermatol (1988) 124: 1097-100.
16. Raymond JZ, Goldman HM, An unusual cutaneous reaction secondary to allopurinol. Cutis (1988) 41: 323-6.
17. Bagot M, Wechsler J. Perrussel M et al, Pseudolymphome induit par la ciclosporine. Ann Dermatol Venereol (1989) 116: 894-6.
18. Lavrijen APM, Van Dijke C, Vermeer BJ, Diltiazem-associated exfoliative dermatitis in a patient with psoriasis. Acta Derm Venereol (Stockh) (1986) 66: 536-8.
19. Furness PN, Goodfield MJ, Maclennan KA et al, Severe cutaneous reactions to captopril and enalapril: histological study and comparison with early mycosis fungoides. J Clin Pathol (1986) 39: 902-7.
20. Mills RM, Severe hypersensitivity reactions associated with allopurinol. JAMA (1971) 216: 799-802.
21. Sotolongo RP, Necfe LI, Rudzki C, Ishak KG, Hypersensitivity reaction to sulfasalazine with severe hepatotoxicity. Gastroenterology (1978) 75: 95-9.
22. Sawaishi Y, Komatsu K, Takeda O et al, A case of tubulo-interstitial nephritis with exfoliative dermatitis and hepatitis due to phenobarbital hypersensitivity. Eur J Pediatr (1992) 151: 69-72.
23. Stern R, Khalsa JH, Cutaneous adverse reaction associated with calcium channel blockers. Arch Intern Med (1989) 149: 829-32.
24. Tomecki KJ, Catalano CJ, Dapsone hypersensitivity. The sulfone syndrome revisited. Arch Dermatol (1981) 117: 38-9.
25. Davies MG, Kersey PJW, Acute hepatitis and exfoliative dermatitis associated with minocycline. BMJ (1989) 298: 1523-4.
26. Maberly DJ, Greenhalgh RM. Jaundice and exfoliative dermatitis due to phenylbutazone. Br J Dermatol (1970) 82: 618-19.
27. Henderson CA, Shamy HK, Atenolol-induced pseudolymphoma. Clin Exp Dermatol (1990) 15: 119-20.
28. Diffee JJ, Hayes JM, Montesi SC et al, Chlorpropamide-induced pulmonary infiltration and eosinophilia with multisystem toxicity. J Tenn Med Assoc (1986) 79: 82-4.
29. Prussick R, Shear NH, Dapsone hypersensitivity syndrome. J Am Acad Dermatol (1996) 35: 346-9.
30. Compton MR, Crosby DL, Rhabdomyolysis associated with azathioprine hypersensitivity syndrome. Arch Dermatol (1996) 132: 1254-5.
31. Knowles SR, Shapiro L, Shear NH, Serious adverse reactions induced by minocycline. Report of 13 patients and review of the literature. Arch Dermatol (1996) 132: 934-9.
32. Cox NH, Johnston SRD, Marks J, Bates D, Extensive carbamazepine eruption with eosinophilia and pulmonary infiltrate. Postgrad Med J (1988) 64: 249-54.
33. De Vriese ASP, Philippe J, Van Renterghem DM et al, Carbamazepine hypersensitivity syndrome: report of 4 cases and review of the literature. Medicine (1995) 74: 144-51.
34. Goodfield MJ, Millard LG, Severe cutaneous reactions to captopril. BMJ (1985) 290: 1111.
35. Bonnetblanc JM, Drug hypersensitivity syndrome. Dermatology (1993) 187: 84-5.
36. Callot V, Roujeau JC, Bagot M et al, Drug induced pseudolymphoma and hypersensitivity syndrome. Two different clinical entities. Arch Dermatol (1996) 132: 1315-21.
37. Bocquet H, Bagot M, Roujeau JC, Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg (1996) 15: 250-7.
38. Roujeau JC, Stern RS, Severe adverse cutaneous reactions to drugs. N Engl J Med (1994) 331: 1272-85.
39. Silverman AK, Fairley J, Wong RC, Cutaneous and immunologic reactions to phenytoin. J Am Acad Dermatol (1988) 18: 721-41.
40. Vittorio CC, Muglia JJ, Anticonvulsant hypersensitivity syndrome. Arch Intern Med (1995) 155: 2285-90.
41. Kleir RS, Breneman DL, Boiho S. Generalized pustulation as a manifestation of the anticonvulsant hypersensitivity syndrome. Arch Dermatol (1991) 127: 1361-4.
42. Kardaun SH, Scheffer E, Vermeer BJ, Drug induced pseudolymphomatous skin reactions. Br J Dermatol (1988) 118: 545-52.
43. Parker WA, Shearer CA, Phenytoin hepatotoxicity: a case report and review. Neurology (1979) 29: 175-8.
44. Ting S, Dunsky EH, Diphenylhydantoin-induced hepatitis. Ann Allergy (1982) 48: 331-2.
45. Handfield-Jones SE, Jankins RE, Whittaker SJ et al, The anticonvulsant hypersensitivity syndrome. Br J Dermatol (1991) 129: 175-7.
46. Tennis P, Stern RS, Risk of serious cutaneous disorders after initialion of use of phenytoin, carbamazepine or sodium valproate: a record linkage study. Neurology (1997) 49: 542-6.
47. Jones D, Chiap V, Resor S et al, Phenytoin-like hypersensitivity associaled with lamotrigine. J Am Acad Dermatol (1997) 36: 1016-18.
48. Grossman SJ, Jollow DJ, Role of dapsone hydroxylamine in dapsone-induced hemolytic anemia. J Pharmacol Exp Ther (1988) 244: 118-25.
49. Shear NH, Spielberg SP, Grant DM et al, Differences in metabolism of suifonamides predisposing to idiosyncratic toxicity. Ann Intern Med (1986) 105: 179-84.
50. Rieder MJ, Shear NS, Kanee A et al, Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions. Clin Pharmacol Ther (1991) 49: 13-17.
51. Rieder MJ, Vetrecht J, Shear NS et al, Diagnosis of suifonamide hypersensitivity reactions by in-vitro 'rechallenge' with hydroxylamine metabolites. Ann Intern Med (1989) 110: 286-9.
52. Roujeau JC, Kelly JP, Naldi L et al, Medication use and the risk of Stevens-Johnson or toxic epidermal necrolysis. N Engl J Med (1995) 333: 1600-7.
53. Shapiro LE, Knowles SR, Shear NH, Comparative safety of tetracycline, minocycline, and doxycycline. Arch Dermatol (1997) 133: 1224-30.
54. Gleichmann H, Studies on the mechanison of drug sensitization: T-cell dependent popliteal lymph reaction to diphenylhydantoin. Clin Immunol Immunopathol (1981) 18: 203-24.
55. Dosch HM, Jason J, Gelfand EW, Transient antibody deficiency and abnormal T-cells induced by phenytoin. N Engl J Med (1982) 306: 406-9.
56. Bluming A, Homer S, Khiroya R, Selective diphenylhydantoin induced suppression of lymphocyte reactivity in vitro. J Lab Clin Med (1976) 88: 417-22.
57. Descamps V, Bouscarat F, Laglenne S et al, Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome. Br J Dermatol (1997) 137: 605-8.
58. Bocquet H, Bourgault-Villada I, Delfau-Larue MH et al, Syndrome d'hypersensibilité à la dapsone. Clone T circulant transitoire. Ann Dermatol Venereol (1995) 122: 514-16.
59. Shapiro LE, Shear NH, Mechanisms of drug reactions: the metabolic track. Semin Cutan Med Surg (1996) 15: 217-27.
60. Spielberg SP, Gordon GB, Blake DA et al, Predisposition to phenytoin hepatotoxicity assessed in vitro. N Engl J Med (1981) 305: 722-7.
61. Spielberg SP, In vitro assessment of pharmacogenetic susceptibility to toxic drug metabolites in humans. Fed Proc (1984) 43: 2308-13.
62. Gennis MA, Vemori R, Burns CA et al, Familial occurrence of hypersensitivity to phenytoin. Am J Med (1991) 91: 631-4.
63. Shear NH, Spielberg SP, In vitro evaluation of a metabolites of sulfadiazide. Can J Physiol Pharmacol (1985) 63: 1370-2.
64. 7re V, Charue D et al, A slow acetylator genotype is a risk factor for sulphonamide-induced toxic epidermal necrolysis and Stevens-Johnson syndrome. Pharmacogenetics (1995) 5: 255-8.
65. Wolkenstein P, Charue D, Laurent P et al, Metabolic predisposition to cutaneous adverse drug reactions: role in toxic epidermal necrolysis caused by sulfonamides and anticonvulsants. Arch Dermatol (1995) 131: 544-51.
66. Lee BL, Wong D, Bewowitz NL, Sullam PM, Altered pattern of drug metabolism in patients with acquired immuno-deficiency syndrome. Clin Pharmacol Ther (1993) 53: 529-35.
67. Buhl R, Jaffe HA, Holroyd KJ et al, Systemic glutathione deficiency in symptom-free HIV seropositive individuals. Lancet (1989) 2: 1294-8.
68. Chopra S, Levell NJ, Cowley G, Gilkes Jf, Systemic corticosteroids in the phenytoin hypersensitivity syndrome. Br J Dermatol (1996) 134: 1109-12.